TY - JOUR
T1 - State anxiety and cancer-specific anxiety in survivors of breast cancer
AU - Rothrock, Nan E.
AU - Matthews, Alicia K.
AU - Sellergren, Sarah A.
AU - Fleming, Gini
AU - List, Marcy
N1 - Funding Information:
Dr. Rothrock is a Post-Doctoral Fellow in Psychology, Center on Outcomes, Research, and Education, Evanston Northwestern Healthcare, 1001 University Place, Suite 100, Evanston, IL 60201 (E-mail: [email protected]). Dr. Matthews is an Associate Professor, College of Nursing, University of Illinois at Chicago. Ms. Sellergren is a Doctoral Candidate, Committee on Human Development; Dr. Fleming is an Associate Professor of Medicine and Director, Medical Oncology Breast Program; and Dr. List is Associate Director for Administration and Scientific Director, Cancer Clinical Trials Office, University of Chicago. The research was supported in part by a George Family Foundation Grant.
PY - 2004
Y1 - 2004
N2 - The current study aimed to identify rates and predictors (demographic, treatment, and psychological variables) of state and cancer-specific anxiety among survivors of breast cancer. Data were collected through a structured telephone interview with 120 women who were at least one year posttreatment. Rates of state anxiety were substantially lower than were the norms for general medical patients. Cancer-specific anxiety was also mild. In hierarchical regression analyses, higher levels of trait anxiety were associated with state and cancer-specific anxiety (β = .73, p < .001, and β = .34, p < .001, respectively). Higher levels of risk perception were associated only with greater cancer-specific anxiety (β = .03, p = .057). The findings suggest the need for specificity in assessing anxiety among women with a history of breast cancer.
AB - The current study aimed to identify rates and predictors (demographic, treatment, and psychological variables) of state and cancer-specific anxiety among survivors of breast cancer. Data were collected through a structured telephone interview with 120 women who were at least one year posttreatment. Rates of state anxiety were substantially lower than were the norms for general medical patients. Cancer-specific anxiety was also mild. In hierarchical regression analyses, higher levels of trait anxiety were associated with state and cancer-specific anxiety (β = .73, p < .001, and β = .34, p < .001, respectively). Higher levels of risk perception were associated only with greater cancer-specific anxiety (β = .03, p = .057). The findings suggest the need for specificity in assessing anxiety among women with a history of breast cancer.
KW - Anxiety
KW - Breast cancer
KW - Survivorship
UR - http://www.scopus.com/inward/record.url?scp=28844473023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=28844473023&partnerID=8YFLogxK
U2 - 10.1300/J077v22n04_06
DO - 10.1300/J077v22n04_06
M3 - Article
AN - SCOPUS:28844473023
SN - 0734-7332
VL - 22
SP - 93
EP - 109
JO - Journal of Psychosocial Oncology
JF - Journal of Psychosocial Oncology
IS - 4
ER -
